of this exciting research, much of which has been conducted at the Clinical Research Institute of Montreal.
There has been remarkably rapid progress in biochemical knowledge about atrial natriuretic peptides and perhaps now is the time to pause and take stock of the evidence about their postulated physiological functions.
Because in humans and in rats the atrial natriuretic factor is elaborated and localised in the granules of the atrial cardiocytes and is released in the blood, it is suggested that the atrial natriuretic factor is "a true circulatory hormone".4 But is there any evidence for the usual process of secretion from the atrial muscle cell? Certainly there is no evidence that the plasma concentrations attained during applied physiological stimuli (such as stretch of left atrial wall) can evoke acute responses. There is only evidence that large doses or large infusions that produce pharmacological concentrations of atrial natriuretic peptide have effects on the blood vessels (arteries, arterioles, veins), causing relaxation, particularly of precontracted muscle, and on the kidneys, causing natriuresis and diuresis.
Little is yet known of the biosynthesis and processing of atrial natriuretic peptide in, and its release from, the cardiocytes. Interpretation of the observed changes in granulation in relation to changes in fluid balance1 2 is at present difficult in view of studies5 6
Requests for reprints to Professor R J Linden, Department of Cardiovascular Studies, University of Leeds, Leeds LS2 9JT. which suggest that granulation is dependent on release rather than synthesis, with low granularity apparently indicating high biosynthesis and turnover; also, in cultured cardiocytes there was an inverse relation between granulation and release of atrial natriuretic peptide.7 It seems likely, however, that in some circumstances low granularity will be associated with low biosynthesis. Exocytosis has not been seen despite specific attempts to detect it in several electron microscope studies,3 7so it is still not certain that the cardiocytes secrete atrial natriuretic peptides by mechanisms analogous to those found in established endocrine organs. Low molecular weight forms are, however, found in plasma and again controversy is rife, evidence being presented both for the release of the high molecular weight form, for the later cleavage in plasma,89 and for the release of the low molecular weight form.10
Few studies have considered quantitatively the problem of the possible physiological stimuli for release and in these no evidence has been provided of a causative relation between stimuli within the physiological range, a rise in the plasma concentration of atrial natriuretic peptide, and the response of natriuresis and diuresis. For instance, the secretion of atrial natriuretic peptide and a causative relation have been implied" in the diuresis and natriuresis arising from stimulation of receptors in the atriathe so-called volume receptors. 12 We suggested that such evidence must call seriously into question the claim that atrial natriuretic peptides are released into plasma in sufficient concentration for natriuresis to be a normal physiological function of these substances.
These investigations also support the contention that the plasma concentrations of atrial natriuretic peptide that evoke responses after infusion are much higher than those attained by stretching the atria or in disease. Normal endogenous basal concentrations of atrial natriuretic peptide are reported to be below 40 fmol/ml (100 pg/ml)"4 15 8 
